How I Knew I Had Inflammatory Breast Cancer

Inflammatory Breast Cancer Often Mistaken for Skin Infection – Content Inflammatory breast cancer accounts for 1 to 5% of all breast cancers, according to the National Cancer Institute, and is often mistaken for a breast infection like mastitis or a skin infection like cellulitis.

The symptoms – skin redness, swelling, and pain – can be similar, although inflammatory breast cancer is also associated with skin thickening and a pitted appearance that resembles an orange peel.
It’s common and appropriate for a primary care doctor to prescribe antibiotics when these symptoms are present, said Jeremy Force, MD, Finley’s medical oncologist and an expert in inflammatory breast cancer at the Duke Cancer Center in Durham.

Problems arise when the symptoms don’t go away. “If symptoms get worse, people need to follow up with their doctor and ask what’s next,” Dr. Force said. Inflammatory breast cancer can be cured if caught early but left untreated, it can spread or metastasize beyond the breast quickly.

Contents

- 0.0.1 What was your first symptom of inflammatory breast cancer?
0.1 How I knew I had inflammatory breast cancer stories?

1 What are the most common symptoms of inflammatory breast cancer?
2 Has anyone survived inflammatory breast cancer?
3 Can you have inflammatory breast cancer and not know it?
4 Can IBC go away?
5 Can IBC happen overnight?
- 5.1 Can inflammation be mistaken for cancer?
6 What is the mimic of inflammatory breast cancer?

What was your first symptom of inflammatory breast cancer?

Signs and symptoms of inflammatory breast cancer – Inflammatory breast cancer (IBC) can cause a number of signs and symptoms, most of which develop quickly (within 3 to 6 months), including:

Swelling (edema) of the skin of the breast Redness involving more than one-third of the breast Pitting or thickening of the skin of the breast so that it may look and feel like an orange peel A retracted or inverted nipple One breast looking larger than the other because of swelling One breast feeling warmer and heavier than the other A breast that may be tender, painful, or itchy Swelling of the lymph nodes under the arms or near the collarbone

If you have any of these symptoms, it does not mean that you have IBC, but you should see a doctor right away. Tenderness, redness, warmth, and itching are also common symptoms of a breast infection or inflammation, such as mastitis if you’re pregnant or breastfeeding.

Because these problems are much more common than IBC, your doctor might suspect infection at first as a cause and treat you with antibiotics. Treatment with antibiotics may be a good first step, but if your symptoms don’t get better in 7 to 10 days, more tests need to be done to look for cancer. Let your doctor know if it doesn’t help, especially if the symptoms get worse or the affected area gets larger.

The possibility of IBC should be considered more strongly if you have these symptoms and are not pregnant or breastfeeding, or have been through menopause. Ask to see a specialist (like a breast surgeon) if you’re concerned. IBC grows and spreads quickly, so the cancer may have already spread to nearby lymph nodes by the time symptoms are noticed.

How I knew I had inflammatory breast cancer stories?

Caroline: Spreading the Word About Inflammatory Breast Cancer – “This is a part of my life I would like to go away — I know it can’t, so I’m creating a new vision of what my life will look like that includes spreading the word.” Caroline McGuirk, diagnosed with stage 4 inflammatory breast cancer (IBC), is committed to teaching others that there is more than one symptom of breast cancer.

When she noticed redness and swelling in her right breast, she didn’t think much of it until two lumps appeared a few months later.
My breast was swelling so subtly that I didn’t notice it at first,” she recalls.
About a month later, my skin on that breast began changing, with some redness and dimpling in places.

Because I was 31 and healthy, I never imagined it was cancer.” Caroline underwent 20 weeks of chemotherapy, a modified radical right-side mastectomy with lymph node removal, and six weeks of radiation at Dana-Farber, away from her work in southern California.

What are the most common symptoms of inflammatory breast cancer?

Inflammatory Breast Cancer Inflammatory breast cancer is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed.

Inflammatory breast cancer is rare, accounting for 1 to 5 percent of all breast cancers diagnosed in the United States. Most inflammatory breast cancers are invasive ductal carcinomas, which means they developed from cells that line the milk ducts of the breast and then spread beyond the ducts. Inflammatory breast cancer progresses rapidly, often in a matter of weeks or months.

At diagnosis, inflammatory breast cancer is either III or IV disease, depending on whether cancer cells have spread only to nearby lymph nodes or to other tissues as well. Additional features of inflammatory breast cancer include the following:

Compared with other types of breast cancer, inflammatory breast cancer tends to be diagnosed at younger ages.
Inflammatory breast cancer is more common and diagnosed at younger ages in African American women than in white women.
Inflammatory breast tumors are frequently negative, which means they cannot be treated with hormone therapies, such as tamoxifen, that interfere with the growth of cancer cells fueled by estrogen.
Inflammatory breast cancer is more common in obese women than in women of normal weight.

Like other types of breast cancer, inflammatory breast cancer can occur in men, but usually at an older age than in women. Symptoms of inflammatory breast cancer include swelling (edema) and redness (erythema) that affect a third or more of the breast.

The skin of the breast may also appear pink, reddish purple, or bruised. In addition, the skin may have ridges or appear pitted, like the skin of an orange (called ). These symptoms are caused by the buildup of fluid (lymph) in the skin of the breast. This fluid buildup occurs because cancer cells have blocked lymph vessels in the skin, preventing the normal flow of lymph through the tissue.

Sometimes the breast may contain a solid tumor that can be felt during a physical exam, but more often a tumor cannot be felt. Other symptoms of inflammatory breast cancer include a rapid increase in breast size; sensations of heaviness, burning, or tenderness in the breast; or a nipple that is inverted (facing inward).

Swollen lymph nodes may also be present under the arm, near the collarbone, or both. It is important to note that these symptoms may also be signs of other diseases or conditions, such as an infection, injury, or another type of breast cancer that is locally advanced. For this reason, women with inflammatory breast cancer often have a delayed diagnosis of their disease.

Inflammatory breast cancer can be difficult to diagnose. Often, there is no lump that can be felt during a physical exam or seen in a, In addition, most women diagnosed with inflammatory breast cancer have dense breast tissue, which makes cancer detection in a screening mammogram more difficult.

Also, because inflammatory breast cancer is so aggressive, it can arise between scheduled screening mammograms and progress quickly.
The symptoms of inflammatory breast cancer may be mistaken for those of mastitis, which is an infection of the breast, or another form of breast cancer.
To help prevent delays in diagnosis and in choosing the best course of treatment, an international panel of experts published guidelines on how doctors can diagnose and stage inflammatory breast cancer correctly.

Their recommendations are summarized below. Minimum criteria for a diagnosis of inflammatory breast cancer include the following:

A rapid onset of erythema (redness), edema (swelling), and a appearance (ridged or pitted skin) and/or abnormal breast warmth, with or without a lump that can be felt.
The above-mentioned symptoms have been present for less than 6 months.
The erythema covers at least a third of the breast.
Initial biopsy samples from the affected breast show invasive carcinoma.

Further examination of tissue from the affected breast should include testing to see if the cancer cells have hormone receptors (estrogen and progesterone receptors) or if they have greater than normal amounts of the HER2 gene and/or the HER2 protein (HER2-positive breast cancer).

Imaging and staging tests include the following: Proper diagnosis and staging of inflammatory breast cancer helps doctors develop the best treatment plan and estimate the likely outcome of the disease.
Patients diagnosed with inflammatory breast cancer may want to consult a doctor who specializes in this disease.

Inflammatory breast cancer is generally treated first with to help shrink the tumor, then with surgery to remove the tumor, followed by, This approach to treatment is called a multimodal approach. Studies have found that women with inflammatory breast cancer who are treated with a multimodal approach have better responses to therapy and longer survival.

Neoadjuvant chemotherapy: This type of chemotherapy is given before surgery and usually includes both and drugs. Doctors generally recommend that at least six cycles of neoadjuvant chemotherapy be given over the course of 4 to 6 months before the tumor is removed, unless the disease continues to progress during this time and doctors decide that surgery should not be delayed.
Targeted therapy: Inflammatory breast cancers often produce greater than normal amounts of the HER2 protein, which means that drugs such as (Herceptin) that target this protein may be used to treat them. Anti-HER2 therapy can be given both as part of neoadjuvant therapy and after surgery (adjuvant therapy).
Hormone therapy: If the cells of a woman’s inflammatory breast cancer contain hormone receptors, hormone therapy is another treatment option. Drugs such as, which prevent estrogen from binding to its receptor, and aromatase inhibitors such as, which block the body’s ability to make estrogen, can cause estrogen-dependent cancer cells to stop growing and die.
Surgery: The standard surgery for inflammatory breast cancer is a modified radical mastectomy. This surgery involves removal of the entire affected breast and most or all of the lymph nodes under the adjacent arm. Often, the lining over the underlying chest muscles is also removed, but the chest muscles are preserved. Sometimes, however, the smaller chest muscle (pectoralis minor) may be removed, too.
Radiation therapy: Post-mastectomy radiation therapy to the chest wall under the breast that was removed is a standard part of multimodal therapy for inflammatory breast cancer. If a woman received trastuzumab before surgery, she may continue to receive it during postoperative radiation therapy. can be performed in women with inflammatory breast cancer, but, due to the importance of radiation therapy in treating this disease, experts generally recommend delayed reconstruction.
Adjuvant therapy: Adjuvant systemic therapy may be given after surgery to reduce the chance of cancer recurrence. This therapy may include additional chemotherapy, hormone therapy, targeted therapy (such as trastuzumab), or some combination of these treatments.

The prognosis, or likely outcome, for a patient diagnosed with cancer is often viewed as the chance that the cancer will be treated successfully and that the patient will recover completely. Many factors can influence a cancer patient’s prognosis, including the type and location of the cancer, the of the disease, the patient’s age and overall general health, and the extent to which the patient’s disease responds to treatment.

Because inflammatory breast cancer usually develops quickly and spreads aggressively to other parts of the body, women diagnosed with this disease, in general, do not survive as long as women diagnosed with other types of breast cancer. It is important to keep in mind, however, that survival statistics are based on large numbers of patients and that an individual woman’s prognosis could be better or worse, depending on her tumor characteristics and medical history.

You might be interested: How To Delete A Whatsapp Message

Women who have inflammatory breast cancer are encouraged to talk with their doctor about their prognosis, given their particular situation. Ongoing research, especially at the molecular level, will increase our understanding of how inflammatory breast cancer begins and progresses.

This knowledge should enable the development of new treatments and more accurate prognoses for women diagnosed with this disease. It is important, therefore, that women who are diagnosed with inflammatory breast cancer talk with their doctor about the option of participating in a clinical trial. NCI sponsors clinical trials of new treatments for all types of cancer, as well as trials that test better ways to use existing treatments.

Participation in clinical trials is an option for many patients with inflammatory breast cancer, and all patients with this disease are encouraged to consider treatment in a clinical trial. Descriptions of ongoing clinical trials for individuals with inflammatory breast cancer can be accessed by searching NCI’s,

NCI’s list of cancer clinical trials includes all NCI-supported clinical trials that are taking place across the United States and Canada, including the NIH Clinical Center in Bethesda, MD. For information about how to search the list, see, People interested in taking part in a clinical trial should talk with their doctor.

Information about clinical trials is available from NCI’s Cancer Information Service at 1–800–4–CANCER ( 1–800–422–6237) and in the NCI booklet, Additional information about clinical trials is available,

Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH. Epidemiology of inflammatory breast cancer (IBC). Breast Diseases 2005; 22:9-23.
Bertucci F, Ueno NT, Finetti P, et al. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Annals of Oncology 2014; 25(2):358-365.
Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer 1998; 82(12):2366-2372.
Dawood S, Cristofanilli M. Inflammatory breast cancer: what progress have we made? Oncology (Williston Park) 2011; 25(3):264-270, 273.
Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology 2011; 22(3):515-523.
Fouad TM, Kogawa T, Reuben JM, Ueno NT. The role of inflammation in inflammatory breast cancer. Advances in Experimental Medicine and Biology 2014; 816:53-73.
Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. Journal of the National Cancer Institute 2005; 97(13):966-975.
Li BD, Sicard MA, Ampil F, et al. Trimodal therapy for inflammatory breast cancer: a surgeon’s perspective. Oncology 2010;79(1-2):3-12.
Masuda H, Brewer TM, Liu DD, et al. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. Annals of Oncology 2014; 25(2):384-91.
Merajver SD, Sabel MS. Inflammatory breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast,3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004.
Ries LAG, Young JL, Keel GE, et al (editors)., Bethesda, MD: NCI SEER Program; 2007. NIH Pub. No.07-6215. Retrieved April 18, 2012.
Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA: A Cancer Journal for Clinicians 2010; 60(6):351-375.
Rueth NM, Lin HY, Bedrosian I, et al. Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database, Journal of Clinical Oncology 2014; 32(19):2018-24.
Schairer C, Li Y, Frawley P, Graubard BI, et al. Risk factors for inflammatory breast cancer and other invasive breast cancers. Journal of the National Cancer Institute 2013; 105(18):1373-1384.
Tsai CJ, Li J, Gonzalez-Angulo AM, et al. Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy. American Journal of Clinical Oncology 2015; 38(3):242-247.
Van Laere SJ, Ueno NT, Finetti P, et al. Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clinical Cancer Research 2013; 19(17):4685-96.
Yamauchi H, Ueno NT. Targeted therapy in inflammatory breast cancer. Cancer 2010; 116(11 Suppl):2758-9.
Yamauchi H, Woodward WA, Valero V, et al. Inflammatory breast cancer: what we know and what we need to learn. The Oncologist 2012; 17(7):891-9.

If you would like to reproduce some or all of this content, see for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product’s title; e.g., “Inflammatory Breast Cancer was originally published by the National Cancer Institute.” : Inflammatory Breast Cancer

Have I got inflammatory breast cancer?

Symptoms – Inflammatory breast cancer doesn’t commonly form a lump, as occurs with other forms of breast cancer. Instead, signs and symptoms of inflammatory breast cancer include:

Rapid change in the appearance of one breast, over the course of several weeks Thickness, heaviness or visible enlargement of one breast Discoloration, giving the breast a red, purple, pink or bruised appearance Unusual warmth of the affected breast Dimpling or ridges on the skin of the affected breast, similar to an orange peel Tenderness, pain or aching Enlarged lymph nodes under the arm, above the collarbone or below the collarbone Flattening or turning inward of the nipple

For inflammatory breast cancer to be diagnosed, these symptoms must have been present for less than six months.

How long can you have IBC without knowing?

Inflammatory breast cancer first signs and symptoms Your breast also may look red or infected or seem to have a rash. Most of the symptoms of inflammatory breast cancer develop quickly — within three to six months. About 1% to 5% of all breast cancers are inflammatory breast cancers.

How quickly do symptoms of inflammatory breast cancer appear?

Symptoms of IBC progress quickly, over three to six weeks, and may include: Areas of discoloration (red, pink or purple), a bruise or rash spread over one-third of your breast. Dimpling, pitting or thickening of your breast skin that resembles an orange peel.

Can IBC be cured if caught early?

The symptoms – skin redness, swelling, and pain – can be similar, although inflammatory breast cancer is also associated with skin thickening and a pitted appearance that resembles an orange peel. It’s common and appropriate for a primary care doctor to prescribe antibiotics when these symptoms are present, said Jeremy Force, MD, Finley’s medical oncologist and an expert in inflammatory breast cancer at the Duke Cancer Center in Durham.

Has anyone survived inflammatory breast cancer?

What is the survival rate for inflammatory breast cancer? – There are different types of statistics that can help doctors evaluate a person’s chance of recovery from inflammatory breast cancer. These are called survival statistics. A specific type of survival statistic is called the relative survival rate.

It is often used to predict how having cancer may affect life expectancy. Relative survival rate looks at how likely people with inflammatory breast cancer are to survive for a certain amount of time after their initial diagnosis or start of treatment compared to the expected survival of similar people without this cancer.

Example: Here is an example to help explain what a relative survival rate means. Please note this is only an example and not specific to this type of cancer. Let’s assume that the 5-year relative survival rate for a specific type of cancer is 90%. “Percent” means how many out of 100.

Imagine there are 1,000 people without cancer, and based on their age and other characteristics, you expect 900 of the 1,000 to be alive in 5 years. Also imagine there are another 1,000 people similar in age and other characteristics as the first 1,000, but they all have the specific type of cancer that has a 5-year survival rate of 90%.

This means it is expected that 810 of the people with the specific cancer (90% of 900) will be alive in 5 years. It is important to remember that statistics on the survival rates for people with inflammatory breast cancer are only an estimate. They cannot tell an individual person if cancer will or will not shorten their life.

Instead, these statistics describe trends in groups of people previously diagnosed with the same disease, including specific stages of the disease. The 5-year relative survival rate for inflammatory breast cancer in the U.S. is 40%. The survival rates for inflammatory breast cancer vary based on several factors.

These include the stage of cancer, a person’s age and general health, and how well the treatment plan works. Another factor that can affect outcomes is whether the cancer has certain features. If the cancer has spread to the regional lymph nodes, the 5-year relative survival rate is 54%.

If the cancer has spread to a distant part of the body, the 5-year relative survival rate is 19%. Experts measure relative survival rate statistics for inflammatory breast cancer every 5 years. This means the estimate may not reflect the results of advancements in how inflammatory breast cancer is diagnosed or treated from the last 5 years.

Talk with your doctor if you have any questions about this information. Learn more about understanding statistics, Statistics adapted from the American Cancer Society and National Cancer Institute websites. (All sources accessed February 2023.) The next section in this guide is Medical Illustrations,

Can you have inflammatory breast cancer and not know it?

Inflammatory breast cancer (IBC) accounts for only about 2-4% of new breast cancer diagnoses each year. But because it’s so aggressive, it makes up a disproportionate number of breast cancer-related deaths annually, even though it’s rare. “IBC has been called both ‘the silent killer’ and ‘the master metastasizer,’ because it’s often misdiagnosed and it spreads so quickly,” explains Wendy Woodward, M.D., Ph.D.

“That’s why speed is so critical in both the diagnosis and treatment of inflammatory breast cancer.” We spoke with Woodward to learn more. Here’s what she wants people to know about inflammatory breast cancer. What are the symptoms of inflammatory breast cancer, and how do they differ from other types? Classic inflammatory breast cancer symptoms develop fairly quickly (3 months or less), and can include swollen breasts, red skin and nipple inversion.

Unlike other types of breast cancer, inflammatory breast cancer doesn’t usually show up as a lump or appear in a screening mammogram, which is why it’s often misdiagnosed. Is there a genetic component to this disease? Are any screening tests available? Unfortunately, no.

There’s no inheritable component of inflammatory breast cancer that’s useful for genetic testing today.
And because its symptoms can come on so quickly — often between mammograms — scan-based screening is largely ineffective for this disease.
Its widespread distribution throughout the breast tissue (often, without a lump you can feel) can also make mammograms appear negative, even when there are obvious changes to the skin.

Are some people more likely to develop inflammatory breast cancer than others? Yes. IBC tends to occur most in two groups: post-menopausal women and young mothers. In the latter, its development seems to be influenced by normal changes that take place in breast tissue after childbirth (from dormancy to active milk production and back again).

Why is getting an accurate diagnosis so important with inflammatory breast cancer? Many women report being misdiagnosed with infections or mastitis (inflammation of the breast tissue) for months before learning they actually have inflammatory breast cancer.
So, the first issue is getting a breast cancer diagnosis, so you can start treatment.

The second issue is making sure treatment decisions are specific to inflammatory breast cancer. Many options are available if the disease recurs, but the best chance at a cure is to prevent recurrence altogether with the most effective combination of chemotherapy, surgery and radiation therapy up front.

You might be interested: How Do You Get Referred To An Nhs Dentist

How is inflammatory breast cancer typically treated? Chemotherapy has to come first, in order to get the best results from surgery. After chemotherapy, inflammatory breast cancer patients typically undergo a mastectomy, a surgery that removes all of the cancerous tissue involved. That includes any skin that’s affected, so leaving some behind in order to place expanders or do immediate reconstruction is not appropriate.

Finally, radiation therapy will be used to target larger areas; in some cases, higher doses of radiation must be used. What should patients look for when deciding where to seek treatment? Because this disease is so aggressive and rare, where you go first for your inflammatory breast cancer treatment makes a big difference.

To ensure you get an accurate diagnosis and the correct treatment from the beginning, it’s important to go to a large, comprehensive cancer center like MD Anderson, Here, we offer patients two important benefits: specialized clinical trials and high-volume experience. Our physicians see multiple patients with inflammatory breast cancer every week, so we are the experts.

And our results demonstrate that. We have some of the best published results in the country for treating inflammatory breast cancer. Our multidisciplinary approach enables patients to visit with all three types of specialists (breast oncology, radiation oncology and surgical oncology) quickly.

They work together closely and in collaboration with our pathologists, radiologists and other specialists to provide the best treatment possible for each patient. That means patients can find everything they need right here. And that doesn’t just include your clinical care. It also includes support services such as social worker counselors, support groups and even one-on-one support from other survivors.

What clinical trials are available right now? Any new developments on the horizon? A number of clinical trials are available especially for patients with inflammatory breast cancer, including several that pair targeted therapy with radiation therapy or chemotherapy.

One trial developed here at MD Anderson combines panitumumab — a targeted therapy drug normally used to treat colorectal cancer — with chemotherapy. This drug had some very high complete response rates in patients with triple-negative inflammatory breast cancer during its first study. We’re also working to understand how changes in normal breast tissue influence the disease pattern, so we can generate new models to study it and identify new targets.

More detailed genetics and immune profiling data are becoming available, too, opening the door to new directions as we work to understand and target this disease. Has the outlook for patients with inflammatory breast cancer changed much over the past few years? Yes.

Patients with inflammatory breast cancer are living longer and seeing fewer misdiagnoses than they did a decade ago. We’ve also been able to safely reduce radiation doses in some patients who respond exceptionally well to chemotherapy. What’s the one thing you want people to know about inflammatory breast cancer? There is hope.

We are making incremental advances, without question. Request an appointment at MD Anderson online or by calling 1-877-632-6789.

What is the best way to diagnose inflammatory breast cancer?

How inflammatory breast cancer is diagnosed – There are many tests used for diagnosing inflammatory breast cancer. Not all tests described here will be used for every person. Your doctor may consider these factors when choosing a diagnostic test:

The type of cancer suspected Your signs and symptoms Your age and general health The results of earlier medical tests

Inflammatory breast cancer is usually diagnosed through a physical examination of the breast and nearby lymph nodes and based on a person’s symptoms. Breast imaging tests and a biopsy of the breast and/or skin are also needed to confirm a diagnosis of inflammatory breast cancer.

Does inflammatory breast cancer show up on an ultrasound?

Can Ultrasound Detect Inflammatory Breast Cancer? – Yes, ultrasound can detect inflammatory breast cancer by identifying irregular masses, thickening of the skin, and fluid collection. Moreover, it can help assess lymph node involvement. It is a critical factor in determining the stage of the disease and the appropriate course of treatment.

Are you tired with inflammatory breast cancer?

Breast cancer causes changes in your body that can lead to fatigue. Many breast cancers release proteins called cytokines, which have been linked to fatigue. Breast cancer also may change your body’s hormone levels and cause inflammation, both of which may contribute to fatigue.

What do IBC spots look like?

If you notice a spot on your breast, chances are it’s harmless. However, certain rare types of breast cancer may cause a red spot, so it’s important to know when to talk to your doctor. If you have a red spot on your breast that appears to be a pimple or bug bite, it could very well be either of those.

The spot could also be due to an infection, allergic reaction, or other skin irritation.
Most types of breast cancer don’t cause red spots on the breast.
There are a few types that can, but they’re rare.
Let’s take a look at these uncommon breast cancers and other conditions that can cause red spots on the breast, as well as signs that you should see your doctor.

It’s not common, but a red spot on the breast can sometimes be a sign of breast cancer. Inflammatory breast cancer (IBC) is rare, making up about 2 to 4 percent of breast cancer cases. A small red spot that looks very much like an insect bite or rash can be an early sign of IBC.

This type of breast cancer is aggressive.
It usually involves the lymph nodes by the time of diagnosis.
Another rare type of breast cancer is called Paget’s disease of the breast,
It makes up about 1 to 4.3 percent of all breast cancers.
In some cases, it can cause a red lesion on the nipple or areola, which can look like an insect bite or eczema.

When you think of signs of breast cancer, you probably think about the discovery of a lump. IBC is different than most types of breast cancer in that it usually doesn’t involve a tumor you can feel, at least in the early stages. You might not have any symptoms at all until the lymph vessels become involved.

breast tenderness or painitchingrednessswellingskin that feels warm to the touchpitted or dimpled skin that resembles an orange peelskin that looks like a rash, hives, or bruisenipple flattening or inversionswollen lymph glands on the neck or under the armsone or more lumps in the breast

Paget’s disease begins with a lesion at the nipple or areola. It can advance to surrounding skin. Signs and symptoms of Paget’s disease can include:

thickening of lesionsrednessitchingtinglingpainscaling, flaking, or crusting of skin around the nipplenipple flattening or inversionyellow or bloody nipple discharge

Bug bites can look like pimples or rashes. They appear suddenly and are typically itchy. Here’s how to recognize some bug bites you might find on your breast:

Flea bites look like small red bumps arranged in groups of three. Mosquito bites are puffy white and red bumps. Bedbug bites are clusters of three to five bites in a zigzag pattern. Scabies look like tiny bumps or blisters that form thin, irregular burrow tracks. Itching tends to get worse at night.

Although pimples most often develop on the face, back, shoulders, and chest, they can also form on your breasts. Here are some ways to identify acne on your breasts:

Whiteheads look like bumps just under the surface of the skin. Blackheads are darker bumps on the surface of the skin. Papules are small pink bumps that may feel a bit tender. Pustules look red at the bottom with pus on top. Nodules are large solid bumps that form deep in the skin. They may be painful. Cysts are deep bumps filled with pus. They may be painful.

A red spot on the breast due to cancer may appear as the following:

IBC. A rash with swelling, itching, dimpling, and changes to the nipple. Paget’s disease. Thickening red spot typically on the nipple or areola. You may also have:

crustingscalingnipple dischargeother changes to the nipple

Here are some more potential causes for red spots on your breast.

What is the mimic of inflammatory breast cancer?

Fat necrosis – Fat necrosis is a proliferative condition commonly seen as a result of breast surgery, infection, trauma, or radiation. Fat necrosis comprises 2.75% of breast lesions and is incited by the destruction of adipocytes, which causes an inflammatory process,

Clinical features of fat necrosis include palpable masses, pain, and skin changes such as skin tethering, skin thickening, and dimpling, Fat necrosis has a wide spectrum of imaging features, some of which show the typical, classically benign findings, such as dystrophic calcifications or oil cysts. However, there are other imaging findings that can closely mimic malignancy: suspicious mammographic features of fat necrosis include irregular and spiculated masses, architectural distortion, asymmetries, coarse heterogeneous and even branching or pleomorphic calcifications.

Nikki’s Inflammatory Breast Cancer Story: \

Ultrasound features of fat necrosis that mimic malignancy include irregular hypoechoic masses with posterior acoustic shadowing (Fig.6 ). Characteristically benign features of fat necrosis on MRI include one or more fat-containing masses, which demonstrate T1 hyperintensity on non-fat supresed T1 sequences with corresponding drop in signal on fat-suppressed T1 and T2 sequences. Fat necrosis. A 52-year-old woman with remote history of mastopexy presented with a palpable breast mass. Mediolateral oblique mammogram ( a ) shows an irregular mass with spiculated margins, associated coarse rim calcifications (solid arrow), and focal skin thickening (dashed arrow).

Longitudinal grayscale ultrasound ( b ) shows a non-parallel irregular hypoechoic mass (arrow). Fat-suppressed axial post-contrast T1-weighted breast MRI ( c ) shows an irregular mass with spiculated margins (arrow) with associated singal void artifact related to post-biopsy clip marker. Ultrasound-guided biopsy showed fat necrosis.

Repeat biopsy under MRI guidance confirmed the diagnosis of fat necrosis The management of fat necrosis is based on the imaging features. Typical benign imaging features do not require further workup. Suspicious features including irregular masses, suspicious calcifications, and architectural distortions require image-guided biopsy.

The radiologic-pathologic correlation of the suspicious imaging features of fat necrosis require the radiologist’s familiarity with the wide spectrum of suspicious imaging features of fat necrosis as well as careful review of the biopsy technique and confirmation of adequate sampling.
Determining concordance can be challenging, especially on MRI-guided biopsies where the target may not remain visible and adequacy of sampling may be difficult to judge.

If needed, a short-term follow-up MRI after biopsy may be recommended.

Is inflammatory breast cancer itchy?

Inflammatory breast cancer – Inflammatory breast cancer is a rare type of breast cancer that can cause skin changes in your breast. With this type of cancer, the breast or part of the breast can become red, inflamed, painful and swollen. It can also cause itching of the breast.

Can you live a long life with IBC?

Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer. Instead of forming a lump, the disease causes the affected breast to become swollen, red and tender, often in a matter of days or weeks. Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer.

Instead of forming a lump, the disease causes the affected breast to become swollen, red and tender, often in a matter of days or weeks. These symptoms are not caused by inflammation. Instead, they are caused by cancer cells blocking lymph vessels in the skin and soft tissue. Lymph is a clear fluid that contains tissue waste and cells that help fight infection.

It travels through the body in vessels that are similar to veins. When these vessels are blocked by cancer cells, lymph builds up in the breast, causing it to swell. Like more common forms of breast cancer, IBC can be divided into three molecular subtypes that can fuel the cancer’s growth and spread: HER2-positive, hormone receptor positive, and triple-negative.

Compared to non-inflammatory breast cancer, IBC is more often HER2-positive or triple-negative.
These subtypes impact a patient’s treatment and prognosis.
Learn more about these molecular subtypes on our main breast cancer site.
IBC is an aggressive disease, with a historically reported five-year survival rate around 40%.

Advances in care are helping more patients live longer, though. Recent studies have shown that with the right treatment IBC’s five-year survival rate is closer to 70% for stage III patients, and up to 50% for newly diagnosed stage IV patients.

Can IBC go away?

Symptoms of inflammatory breast cancer may fluctuate over time or become more intense, depending on the cancer’s growth. According to the American Cancer Society, inflammatory breast cancer (IBC) accounts for roughly 1 to 5 percent of all breast cancer diagnoses.

You might be interested: How To Factory Reset Oculus Quest 2

Unlike other noninflammatory forms of breast cancer, IBC tends to cause an entirely separate set of symptoms. In some cases, these symptoms can come and go and vary in severity or intensity, depending on how quickly the cancer is growing. Here, we’ll explore the most common symptoms of IBC, including the pattern of when they come and go and whether they could be due to another underlying condition.

IBC symptoms tend to be more prominent and severe than those of noninflammatory breast cancers. Common symptoms may include:

breast edema ( swelling )breast rednessbreast skin that is thick or pitted an inverted or retracted nipplean increase in breast sizewarmth and heaviness in the breasttenderness or pain in the breast or surrounding area itching in or around the breast swollen lymph nodes

IBC symptoms are caused by a blockage of the lymphatic system within the breast, which causes pain and swelling. Many of these symptoms develop quickly, usually within a period of 3 to 6 months, IBC is a fast-growing, aggressive form of breast cancer.

Unlike other types of breast cancer, symptoms of this condition are primarily caused by inflammation, which leads to swelling, pain, redness, and other symptoms. When the symptoms of IBC appear, they may come and go in the beginning. In fact, some of the symptoms mentioned above can appear suddenly and may be mistaken for another condition with similar symptoms, such as an infection or rash.

However, unlike other conditions that resolve over time with treatment, the symptoms of IBC become worse over a period of weeks or months. Although they may vary in intensity, once the cancer has begun to spread, it will continue to cause pain, swelling, and other symptoms in the affected breast.

Can IBC happen overnight?

Symptoms often develop quite suddenly. The breast may become: red and inflamed.

Can inflammation be mistaken for cancer?

Inflammatory conditions, such as rheumatoid arthritis, can also result in soft tissue masses. Even metabolic conditions, such as hyperlipidemia (high blood fat levels), can cause masses to form that may look like tumors.

Where does IBC rash start?

Redness or another change in the skin color of the breast, swelling on one side and/or a rash that appears quickly — sometimes literally overnight — are the hallmark symptoms of inflammatory breast cancer, But what does that rash actually look like? And how can you distinguish it from other, more benign conditions? To learn more, we went to Wendy Woodward, M.D., Ph.D.

A radiation oncologist and researcher who specializes in the treatment of inflammatory breast cancer,
What does an inflammatory breast cancer rash look like? That’s kind of hard to say, because not everyone’s rash looks the same.
And, it doesn’t always look like a rash.
Sometimes, you can just see the breast skin pores very clearly because they look exaggerated due to swelling.

Or, there’s redness or some other type of discoloration of one breast. The rash associated with inflammatory breast cancer can also vary in appearance based on someone’s skin tone. It may look dark or even purple on some women, rather than red. But there’s not a defining skin change that’s the same for everybody.

And, no matter how early a rash is diagnosed as inflammatory breast cancer, it is always considered at least stage III. What characteristics distinguish an inflammatory breast cancer rash from other kinds? Speed is one factor. Inflammatory breast cancer is quite aggressive, and it can develop very, very quickly.

So, if you notice a marked change in the size of your breast or in its color or texture over a few weeks — or even a few days or hours — you should get it evaluated right away. In addition, though some women describe the rash as starting out small — or even resembling a bug bite — it often involves most of the breast within a very short time frame.

So, a spreading rash deserves prompt attention, too.
Are there any other conditions that can cause rashes on the breast? Yes.
Mastitis is the top one.
It’s fairly common during breastfeeding, so many people tend to assume that inflammatory breast cancer is just an infection.
It gets mistaken for mastitis and abscesses a lot because most health care providers have never seen inflammatory breast cancer before.

They tend to err on the side of the rash being caused by something more benign. The number of people diagnosed with inflammatory breast cancer each year is incredibly small. It’s a drop in the bucket, compared to other types of breast cancer. And most people who notice changes in their breasts will not ultimately have breast cancer.

By the time patients get to MD Anderson’s specialized Inflammatory Breast Cancer Clinic, though, they’ve often already gone through multiple rounds of antibiotics with no improvement. Have there been any advances in the diagnosis of inflammatory breast cancer, based on rashes? Yes. We’re working on two different projects right now.

One is an update of the MD Anderson cancer algorithm to help patients obtain a faster diagnosis. If the changes they’ve noticed are enough to point to inflammatory breast cancer, they’ll be able to use this algorithm to back up their request for additional imaging or a breast biopsy,

That way, if a doctor says, “OK, here are some more antibiotics,” patients can say, “Wait.
Shouldn’t we try to rule this out first?” and show them the MD Anderson algorithm.
A lot of doctors think of a breast biopsy as a really big step.
But in this case, it’s not.
It’s just the right thing to do.
We’re also in the very early stages of developing of an app that would let patients take a picture of their own breast, upload it and use artificial intelligence to compare it to photos of both healthy breasts and those from patients with confirmed inflammatory breast cancer diagnoses.

The hope is to give patients a gauge to determine whether their rash is something to be concerned about and doctors a tool to make a diagnosis right away. Is there anything else people should know about inflammatory breast cancer rashes? Yes. Sometimes, it can be hard to distinguish non-inflammatory breast cancer from inflammatory breast cancer, since both can cause redness of the breast and skin changes that might be missed.

But if you notice really rapid changes in one or both of your breasts, try to be seen by a doctor within two weeks.
While a short course of antibiotics is not unreasonable when the suspicion of inflammatory breast cancer is low, don’t be afraid to ask for breast imaging or a biopsy if your symptoms don’t fully resolve in less than two weeks.

If your condition gets better before the results come in, great. But if not, you’ll be that much closer to a diagnosis. Request an appointment at MD Anderson online or by calling 1-877-632-6789.

What does Stage 1 breast cancer feel like?

Symptoms of stage 1 breast cancer include skin irritation or dimpling, swelling/redness/scaling/flaking/thickening of the nipple or breast skin, change in the size or the shape of the breast, nipple turning inward, change in the appearance of a nipple, nipple discharge that is not breast milk, breast pain, nipple pain, new lump in the breast, and a lump in the armpit.

Breast cancer occurs when abnormal cells in the breast grow out of control.
Breast cancer is the most common female cancer in the U.S., and the second-leading cause of cancer death in women ( lung cancer is the leading cause of cancer deaths).
Breast cancer is more common in women, but men can get it too.

Stage 1 breast cancer is cancer still small and localized to the breast and either has not spread to the lymph nodes or a tiny area of cancer has spread to the sentinel lymph node (the first lymph node to which cancer is likely to spread). Symptoms of stage 1 breast cancer include:

Skin irritation or dimpling Swelling of all or part of the breast Redness, scaling, flaking, or thickening of the nipple or breast skin A change in the size or the shape of the breast Nipple turning inward or change in the appearance of a nipple Nipple discharge that is not breast milk Breast pain Nipple pain New lump in the breast A lump in the armpit

What can be mistaken for inflammatory breast cancer?

The symptoms – skin redness, swelling, and pain – can be similar, although inflammatory breast cancer is also associated with skin thickening and a pitted appearance that resembles an orange peel.
It’s common and appropriate for a primary care doctor to prescribe antibiotics when these symptoms are present, said Jeremy Force, MD, Finley’s medical oncologist and an expert in inflammatory breast cancer at the Duke Cancer Center in Durham.

What is the mimic of inflammatory breast cancer?

Clinical features of fat necrosis include palpable masses, pain, and skin changes such as skin tethering, skin thickening, and dimpling, Fat necrosis has a wide spectrum of imaging features, some of which show the typical, classically benign findings, such as dystrophic calcifications or oil cysts. However, there are other imaging findings that can closely mimic malignancy: suspicious mammographic features of fat necrosis include irregular and spiculated masses, architectural distortion, asymmetries, coarse heterogeneous and even branching or pleomorphic calcifications.

Nikki’s Inflammatory Breast Cancer Story: \

Longitudinal grayscale ultrasound ( b ) shows a non-parallel irregular hypoechoic mass (arrow). Fat-suppressed axial post-contrast T1-weighted breast MRI ( c ) shows an irregular mass with spiculated margins (arrow) with associated singal void artifact related to post-biopsy clip marker. Ultrasound-guided biopsy showed fat necrosis.

The radiologic-pathologic correlation of the suspicious imaging features of fat necrosis require the radiologist’s familiarity with the wide spectrum of suspicious imaging features of fat necrosis as well as careful review of the biopsy technique and confirmation of adequate sampling. Determining concordance can be challenging, especially on MRI-guided biopsies where the target may not remain visible and adequacy of sampling may be difficult to judge.

If needed, a short-term follow-up MRI after biopsy may be recommended.

Where does IBC rash start?

Changes in skin typically cover at least one-third of the breast, although some rashes more closely resemble a small insect bite. An early inflammatory breast cancer rash may appear as a bruise that doesn’t go away or a subtle change in breast skin that progresses rapidly over the course of a few weeks.

Does inflammatory breast cancer show up in blood work?

How early can IBC be diagnosed? – Because of IBC’s quick-growing and aggressive nature, combined with its tendency to be misdiagnosed, it’s commonly diagnosed at an advanced stage,

IBC tends to grow in layers, which is why it can be missed during exams. On imaging, these sheets of tissue can resemble nests. Your doctor may be able to feel these areas of thickening on your skin, as well as possibly see areas of higher density on a mammogram. Routine blood tests may not pick up abnormalities related to inflammatory breast cancer.

Skye Skinner